Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.75
-0.70 (-6.70%)
Jan 5, 2026, 4:00 PM EST - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.31 billion as of January 6, 2026. Its market cap has increased by 52.53% in one year.
Market Cap
1.31B
Enterprise Value
820.84M
1-Year Change
52.53%
Ranking
Category
Stock Price
$9.75
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.31B, an increase of 657.75%. That is a compound annual growth rate of 33.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 1.31B | -7.14% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |